Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06405438 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Comparison of the Efficacy of Peloid Therapy and Paraffin Treatment in Carpal Tunnel Syndrome

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated October 26, 2024 (before its estimated January 20, 2025 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Phase: Not applicable to Not specifiedv2 Show 8 more changesShow less
    • Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Jun 1, 2024 to Oct 10, 2024
    • Primary completion date: Sep 1, 2024 to Jan 20, 2025
    • Study completion date: Oct 1, 2024 to Jan 20, 2025
    • Interventions: physical therapy (Other) to No intervention (Other)
    • Secondary endpoints: details revised at 1 of 7 entries
    • Site details revised
    • Study description expanded, about 2 words
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study compares the effectiveness of peloid therapy and paraffin treatment in carpal tunnel syndrome. Patients who have already received 2 weeks of peloid therapy or 15 sessions of paraffin treatment will be assessed. Pain and symptom severity are assessed using the Visual Analog Scale (VAS) and Boston Carpal Tunnel Syndrome Questionnaire (BCTQ). Electrophysiological examinations will also be conducted at the same time points: baseline, 4 weeks post-treatment, and a 12-week follow-up.
Trial Details
NCT Number NCT06405438
Lead Sponsor Beylikduzu State Hospital
Conditions
(from sponsor)		 Carpal Tunnel Syndrome
Related terms Carpal Tunnel Syndrome, Median Neuropathy
Enrollment 60 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov